In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

Published Date: 20 Mar 2024

Breast cancer that manifests in between two screening program reviews is known as interval breast cancer. In other words, a negative test result precedes the next evaluation and the diagnosis is made after that. It is very trustworthy for obvious reasons.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

2.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

3.

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

4.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

5.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot